Laidlaw Wealth Management’s PAVmed PAVM Stock Holding History

Laidlaw Wealth Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-33	Closed	-$32K	–	316
2020 Q4	$32K	Hold	33	–	–	0.01%	352
2020 Q3	$27K	Buy	+33	New	+$29.4K	0.01%	205

Other funds holding PAVM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Laidlaw Wealth Management's PAVM Position: Q1 2021 in Review

Laidlaw Wealth Management sold out of PAVmed (PAVM) in Q1 2021, closing a stake of 33 shares — an estimated $32K sold.

Laidlaw Wealth Management first reported a position in PAVM in Q3 2020 and held it in 2 quarters. The position peaked at $32K in Q4 2020. 91 funds tracked by Wall St. Rank hold PAVM as of Q1 2021.

Laidlaw Wealth Management reported no remaining PAVmed position as of Q1 2021 after selling out during the quarter.
Laidlaw Wealth Management sold 33 PAVmed shares in Q1 2021, an estimated $32K.
Laidlaw Wealth Management first reported a position in PAVmed in Q3 2020 and held it in 2 quarters.
Laidlaw Wealth Management's PAVmed position peaked at $32K in Q4 2020.
91 funds tracked by Wall St. Rank held PAVmed as of Q1 2021.

Based on Laidlaw Wealth Management's 13F filing for Q1 2021, filed 17 May 2021.